IDEXX LABORATORIES INC /DE reported revenue of $1.22B for the period ended 2026-06-30, +9.7% year on year. Net income was $0.34B, a 27.8% net margin on a 64.0% gross margin. The largest revenue line is Companion Animal Group at 92% of the total. Free cash flow for the period was $0.32B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.22B | +9.7% |
| Gross profit | $0.78B | — |
| Operating income | $0.43B | — |
| Net income | $0.34B | +15.1% |
| Gross margin | 64.0% | Net margin 27.8% |
| Revenue Q/Q | +6.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| Companion Animal Group | $1.12B | 91.9% |
| Water | $0.06B | 4.8% |
| Livestock And Poultry Diagnostics | $0.04B | 2.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.44B | 36.0% |
| R&D | $0.07B | 5.4% |
| SG&A | $0.29B | 23.7% |
| Tax & other | $0.09B | 7.2% |
| Item | Amount |
|---|---|
| Total assets | $3.44B |
| Total liabilities | $1.83B |
| Shareholders' equity | $1.61B |
| Equity / assets | 46.8% |
| Operating cash flow | $0.35B |
| Capital expenditure | $0.03B |
| Free cash flow | $0.32B |
| Cash conversion (OCF / net income) | 103% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ITW ・ INCY ・ IR ・ PODD ・ INTC ・ IBKR ・ ICE ・ IFF ・ IP ・ INTU ・ ISRG ・ IVZ
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies